Soligenix Inc (SNGX)
0.3839
-0.01
(-2.22%)
USD |
NASDAQ |
May 20, 16:00
0.394
+0.01
(+2.63%)
After-Hours: 19:21
Soligenix Cash from Operations (Quarterly): -1.342M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.342M |
December 31, 2023 | -1.828M |
September 30, 2023 | -2.686M |
June 30, 2023 | -1.923M |
March 31, 2023 | -2.166M |
December 31, 2022 | -3.627M |
September 30, 2022 | -3.255M |
June 30, 2022 | -2.528M |
March 31, 2022 | -3.239M |
December 31, 2021 | -3.055M |
September 30, 2021 | -3.040M |
June 30, 2021 | -1.659M |
March 31, 2021 | -3.985M |
December 31, 2020 | -4.125M |
September 30, 2020 | -2.991M |
June 30, 2020 | -1.644M |
March 31, 2020 | -2.695M |
December 31, 2019 | -2.643M |
September 30, 2019 | -2.058M |
June 30, 2019 | -0.5151M |
March 31, 2019 | -2.293M |
December 31, 2018 | -2.676M |
September 30, 2018 | -0.9678M |
June 30, 2018 | -2.142M |
March 31, 2018 | -1.459M |
Date | Value |
---|---|
December 31, 2017 | -2.318M |
September 30, 2017 | -1.213M |
June 30, 2017 | -1.353M |
March 31, 2017 | -1.627M |
December 31, 2016 | -1.426M |
September 30, 2016 | -1.205M |
June 30, 2016 | -1.714M |
March 31, 2016 | -0.6378M |
December 31, 2015 | -1.336M |
September 30, 2015 | -0.3346M |
June 30, 2015 | -2.210M |
March 31, 2015 | -1.506M |
December 31, 2014 | -0.3689M |
September 30, 2014 | -0.9976M |
June 30, 2014 | -0.7124M |
March 31, 2014 | -0.3878M |
December 31, 2013 | -1.293M |
September 30, 2013 | -1.717M |
June 30, 2013 | -0.7025M |
March 31, 2013 | -0.7444M |
December 31, 2012 | -0.342M |
September 30, 2012 | -0.7329M |
June 30, 2012 | -0.8851M |
March 31, 2012 | -0.6755M |
December 31, 2011 | -1.222M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.125M
Minimum
Dec 2020
-0.5151M
Maximum
Jun 2019
-2.550M
Average
-2.665M
Median
Cash from Operations (Quarterly) Benchmarks
Eagle Pharmaceuticals Inc | -0.126M |
Marinus Pharmaceuticals Inc | -37.46M |
NovaBay Pharmaceuticals Inc | -1.572M |
Palatin Technologies Inc | -8.607M |
iBio Inc | -4.706M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | -0.009M |
Free Cash Flow | -7.780M |
Free Cash Flow Per Share (Quarterly) | -0.1276 |
Free Cash Flow to Equity (Quarterly) | -1.078M |
Free Cash Flow to Firm (Quarterly) | -1.342M |
Free Cash Flow Yield | -210.3% |